Policy Updates Medical Policy & Clinical GuidelinesCommercialJuly 1, 2024

Coding update effective October 1, 2024

The following guidelines were among those recently approved at the Medical Policy and Technology Assessment Committee meeting held on May 9, 2024. Revisions have been made to the coding that may result in services previously considered medically necessary to now be considered not medically necessary for dates of service on or after October 1, 2024.

Guideline

Code(s)

MED.00013

Parenteral Antibiotics for the Treatment of Lyme Disease

J0688, J0689, J0744, J2184, J2281

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

65778, 65779, 65780, Q4290, V2790

Anthem Blue Cross and Blue Shield is the trade name of Blue Cross Blue Shield Healthcare Plan of Georgia, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

GABCBS-CM-060775-24

PUBLICATIONS: July 2024 Provider Newsletter